The pharmaceutical manufacturers’ specialism in drug development, manufacturing and packaging services will complement PCI’s growth in clinical trial and commercial supply services in both North America and Europe.
As we waited to see whether or not Pfizer would be successful in its takeover of AstraZeneca, the approach has raised several issues for the pharmaceutical sector, says Lu Rahman.
